Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > News > Reducing cirrhosis threat for high-risk drinkers

Reducing cirrhosis threat for high-risk drinkers

Date time 2 September, 2020
News Type News type Media release
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis (scarring of the liver), which causes approximately 300,000 deaths globally each year.

Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis (scarring of the liver), which causes approximately 300,000 deaths globally each year.

Also found by the researchers in this multi-national GenomALC Consortium–involving QIMR Berghofer Medical Research Institute and the Southern California Institute for Research and Education (SCIRE)–is that susceptibility to cirrhosis among high-risk drinkers is affected by a family history of alcohol-induced liver disease.

“Only a minority of high-risk drinkers, approximately 10-15 percent, actually end up developing alcohol-induced cirrhosis. But the survival time for those individuals who do develop this devastating disease can be as low as 1-2 years,” said Clinical Associate Professor Devanshi Seth, Head of the Centenary Institute Alcoholic Liver Disease Research Program and senior author of the published study.

“The best way to reduce harm from alcohol (including cirrhosis) is by reducing or cutting out alcohol. High-risk drinking is chronic alcohol use above the recommended guidelines that may result in cirrhosis. Unfortunately, individuals may not be aware of the dangers that heavy drinking entails. The aim of our study was to identify risks associated with cirrhosis in heavy drinkers and to gain insights into additional measures that could help in preventing or reducing cirrhosis in patients whose drinking places them at risk,” she said.

Lead author of the study, which was published in the prestigious science journal ‘American Journal of Gastroenterology’, was Dr John Whitfield from QIMR Berghofer Medical Research Institute.

Dr Whitfield says their study found evidence that an increased risk of developing alcohol-induced cirrhosis could be inherited, especially from fathers.

“Our study showed that risk of cirrhosis was significantly increased in individuals if the father was a chronic alcohol user and had died from liver disease. We also found that high-risk drinkers who consumed coffee were less likely to develop cirrhosis, while tea drinking only marginally lowered the risk,” Dr Whitfield said.

Dr Timothy Morgan, co-senior author of the study and researcher at the SCIRE notes that they’ve also been able to show that obesity and diabetes are both independently linked with an increased risk of alcohol-induced cirrhosis. “High-risk drinkers who have diabetes in middle age are particularly likely to progress to cirrhosis,” he said.

Clinical Associate Professor Seth believes that their findings may have major public health consequences. “Measures such as maintaining a healthy bodyweight, intensive treatment of diabetes or pre-diabetic states, and encouragement of coffee consumption may be useful lifestyle interventions to reduce the risk of alcohol-induced cirrhosis for high-risk drinkers.” she said.

The research was funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) a part of the National Institutes of Health (NIH), USA.

Read the full media release here.

Publication: Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.

Themes

  • Inflammation

    Inflammation

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • 2GB Healthy Living program interviews Dr Elinor Hortle

    Dr Elinor Hortle, medical researcher at the Centenary Institute has been interviewed on Sydney radio 2GB’s Healthy Living program, discussing her latest findings on tackling mycobacterial infections. Responsible for diseases that include tuberculosis (TB), leprosy and serious skin ulcerations, mycobacterial infections cause significant harm and mortality to human health. Approximately 1.5 million people die each ...
    News Type: Media coverage
    Date 18 May 2022
  • World-first study reveals why people with COPD are more susceptible to COVID-19

    Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19. The findings, reported in the American Journal of Respiratory and Critical Care Medicine,could lead to the development of new therapeutic interventions that ...
    News Type: Media release
    Date 17 May 2022
  • New discovery may hold key to fighting deadly infections

    Centenary Institute research has revealed new insight into tackling mycobacterial infections which are responsible for chronic diseases that include tuberculosis (TB), leprosy and serious skin ulcerations.
    News Type: Media release
    Date 12 May 2022
  • Research Australia’s ‘Inspire Magazine’ features Professor Chris Semsarian AM

    Professor Chris Semsarian AM, Head of the Centenary Institute’s Agnes Ginges Centre for Molecular Cardiology, has featured in an article in Research Australia’s Inspire Magazine outlining the importance of philanthropy to medical research. The article highlights how the philanthropic support of Mrs Agnes Ginges and her husband, the late Mr Berel Ginges (facilitated by eminent ...
    News Type: Media coverage
    Date 03 May 2022

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram